Blood biomarkers associated to complete pathological response on NSCLC patients treated with neoadjuvant chemoimmunotherapy included in NADIM clinical trial

Raquel Laza-Briviesca, Alberto Cruz-Bermúdez, Ernest Nadal, Amelia Insa, María del Rosario García-Campelo, Gerardo Huidobro, Manuel Dómine, Margarita Majem, Delvys Rodríguez-Abreu, Alex Martínez-Martí, Javier De Castro Carpeño, Manuel Cobo, Guillermo López Vivanco, Edel Del Barco, Reyes Bernabé Caro, Nuria Viñolas, Isidoro Barneto Aranda, Santiago Viteri, Bartomeu Massuti, Marta CasarrubiosBelén Sierra-Rodero, Carlos Tarín, Aránzazu García-Grande, Cara Haymaker, Ignacio I. Wistuba, Atocha Romero, Fernando Franco, Mariano Provencio

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Blood biomarkers associated to complete pathological response on NSCLC patients treated with neoadjuvant chemoimmunotherapy included in NADIM clinical trial'. Together they form a unique fingerprint.

Medicine & Life Sciences